203 related articles for article (PubMed ID: 22183971)
1. Long-term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis.
Fahrner B; Prosch H; Minkov M; Krischmann M; Gadner H; Prayer D; Grois N
Pediatr Blood Cancer; 2012 Apr; 58(4):606-10. PubMed ID: 22183971
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
Kaltsas GA; Powles TB; Evanson J; Plowman PN; Drinkwater JE; Jenkins PJ; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2000 Apr; 85(4):1370-6. PubMed ID: 10770168
[TBL] [Abstract][Full Text] [Related]
3. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.
Grois N; Prayer D; Prosch H; Minkov M; Pötschger U; Gadner H
Pediatr Blood Cancer; 2004 Jul; 43(1):59-65. PubMed ID: 15170891
[TBL] [Abstract][Full Text] [Related]
4. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
Leger J; Velasquez A; Garel C; Hassan M; Czernichow P
J Clin Endocrinol Metab; 1999 Jun; 84(6):1954-60. PubMed ID: 10372693
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus in children and young adults.
Maghnie M; Cosi G; Genovese E; Manca-Bitti ML; Cohen A; Zecca S; Tinelli C; Gallucci M; Bernasconi S; Boscherini B; Severi F; Aricò M
N Engl J Med; 2000 Oct; 343(14):998-1007. PubMed ID: 11018166
[TBL] [Abstract][Full Text] [Related]
6. Endocrine changes in histiocytosis of the hypothalamic-pituitary axis.
Toro Galván S; Planas Vilaseca A; Michalopoulou Alevras T; Torres Díaz A; Suárez Balaguer J; Villabona Artero C
Endocrinol Nutr; 2015 Feb; 62(2):72-9. PubMed ID: 25434508
[TBL] [Abstract][Full Text] [Related]
7. Predictor Variables of Developing Anterior Pituitary Deficiencies in a Group of Paediatric Patients with Central Diabetes Insipidus and Langerhans Cell Histiocytosis.
Vaiani E; Malossetti C; Vega LM; Zubizarreta P; Braier J; Belgorosky A
Horm Res Paediatr; 2017; 87(1):51-57. PubMed ID: 27951529
[TBL] [Abstract][Full Text] [Related]
8. Predictors of neoplastic disease in children with isolated pituitary stalk thickening.
Robison NJ; Prabhu SP; Sun P; Chi SN; Kieran MW; Manley PE; Cohen LE; Goumnerova L; Smith ER; Scott RM; London WB; Ullrich NJ
Pediatr Blood Cancer; 2013 Oct; 60(10):1630-5. PubMed ID: 23670879
[TBL] [Abstract][Full Text] [Related]
9. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis.
Maghnie M; Bossi G; Klersy C; Cosi G; Genovese E; Aricò M
J Clin Endocrinol Metab; 1998 Sep; 83(9):3089-94. PubMed ID: 9745408
[TBL] [Abstract][Full Text] [Related]
10. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
[TBL] [Abstract][Full Text] [Related]
11. Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children.
Schmitt S; Wichmann W; Martin E; Zachmann M; Schoenle EJ
Eur J Pediatr; 1993 May; 152(5):399-401. PubMed ID: 8319704
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents.
Mootha SL; Barkovich AJ; Grumbach MM; Edwards MS; Gitelman SE; Kaplan SL; Conte FA
J Clin Endocrinol Metab; 1997 May; 82(5):1362-7. PubMed ID: 9141516
[TBL] [Abstract][Full Text] [Related]
14. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
15. Radiological evaluation of patients with pituitary langerhans cell histiocytosis at diagnosis and at follow-up.
Varan A; Cila A; Akyüz C; Kale G; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Sep; 25(6):567-74. PubMed ID: 18728976
[TBL] [Abstract][Full Text] [Related]
16. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
Czernichow P; Garel C; Léger J
Horm Res; 2000; 53 Suppl 3():61-4. PubMed ID: 10971107
[TBL] [Abstract][Full Text] [Related]
17. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis.
Maghnie M; Aricò M; Villa A; Genovese E; Beluffi G; Severi F
AJNR Am J Neuroradiol; 1992; 13(5):1365-71. PubMed ID: 1414829
[TBL] [Abstract][Full Text] [Related]
18. Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhans cell histiocytosis and diabetes insipidus.
Broadbent V; Dunger DB; Yeomans E; Kendall B
Med Pediatr Oncol; 1993; 21(9):649-54. PubMed ID: 8412998
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis.
Montefusco L; Harari S; Elia D; Rossi A; Specchia C; Torre O; Adda G; Arosio M
Eur J Intern Med; 2018 May; 51():61-67. PubMed ID: 29198444
[TBL] [Abstract][Full Text] [Related]
20. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study.
Grois N; Flucher-Wolfram B; Heitger A; Mostbeck GH; Hofmann J; Gadner H
Med Pediatr Oncol; 1995 Apr; 24(4):248-56. PubMed ID: 7700170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
